GlassScriptPhysician profile
Jordan Feierman
NPI 1902326960
$1,251.94
in general payments reported to CMS, 2019-2025
11 companies · $289 in 2025
The $289 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.21 · 2021: $298 · 2022: $160 · 2023: $360 · 2024: $123 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $504.35 | 2022-2025 | Sprint Pns System |
| Abbott Laboratories | $147.69 | 2021 | |
| Avanos Medical | $132.20 | 2021-2022 | |
| Abbvie INC. | $100.68 | 2025 | |
| Si-Bone, INC. | $92.75 | 2021 | |
| Trice Medical, INC. | $86.85 | 2023 | |
| Merck Sharp & Dohme LLC | $84.72 | 2024-2025 | Bridion |
| Boston Scientific Corporation | $47.09 | 2023-2025 | Na |
| Alnylam Pharmaceuticals INC. | $21.21 | 2019 | |
| Bioventus LLC | $18.44 | 2023 | Durolane |
| Curonix LLC | $15.96 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Feierman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.